Intellia Therapeutics Expands Phase 1 Study to Include Adults with Transthyretin Amyloidosis with Cardiomyopathy

https://ir.intelliatx.com/news-releases/news-release-details/intellia-therapeutics-announces-expansion-ongoing-phase-1-study